Phytochemicals as potential antiviral agents in SARS-CoV-2 therapy: an update

• Autor(a) principal: Lima,Nerilson M.
• Data de Publicação: 2021
• Outros Autores: Andrade,Teresinha de Jesus A. S., Acquah,Kojo S., Oliveira,Marcone A. L. de, Gois,Kellyane F., Medeiros,Lis Cardoso M.
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Química Nova (Online)
• Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-40422021000500667
• topic: SARS-CoV-2; COVID-19; phytotherapy; phytochemicals; antiviral

In December 2019, the World Health Organization officially announced the discovery and fast spread of the new coronavirus disease (COVID-19), which is caused by the SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2), discovered in Wuhan, China. Since the beginning of the pandemic, there has been a global search for the discovery of antiviral candidates capable of treating the infection caused by SARS-CoV-2. However, none of them has shown proved efficacy and low toxicity for an effective dose. In view of this, research with plants based in natural products has been highlighted by the low toxicity of its metabolites and reduced side effects, since plants have been used for millennia in the treatment of various diseases. In this review, we highlight some plant species and plant metabolites belonging to the structural class of phenolic, alkaloids and terpenes with promising antiviral potential against coronavirus that could be explored as potential candidates for drug prototypes in the treatment of COVID-19.